Bioptik Technology (4161) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 聿新科

Bioptik Technology (4161) reported revenue of NT$48.1 million for Oct 2026, -20.3% year on year and +0.9% from the previous month. Revenue for Jan–Oct 2026 was NT$704.1 million (+6.4% year on year).

In Oct 2026, it ranked No. 100 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$61.9 million24/10Nov 2024 NT$85.7 millionDec 2024 NT$80.2 millionJan 2025 NT$53.6 millionFeb 2025 NT$74.4 million25/02Mar 2025 NT$67.7 millionApr 2025 NT$57.2 millionMay 2025 NT$55.2 millionJun 2025 NT$78.1 million25/06Jul 2025 NT$67.6 millionAug 2025 NT$66.6 millionSep 2025 NT$81 millionOct 2025 NT$60.4 million25/10Nov 2025 NT$101 millionDec 2025 NT$74.4 millionJan 2026 NT$74.6 millionFeb 2026 NT$54.6 million26/02Mar 2026 NT$95.1 millionApr 2026 NT$64.5 millionMay 2026 NT$96 millionJun 2026 NT$77.1 million26/06Jul 2026 NT$95.5 millionAug 2026 NT$50.9 millionSep 2026 NT$47.7 millionOct 2026 NT$48.1 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$48.1 million-20.3%+0.9%
Sep 2026NT$47.7 million-41.1%-6.2%
Aug 2026NT$50.9 million-23.6%-46.7%
Jul 2026NT$95.5 million+41.3%+23.8%
Jun 2026NT$77.1 million-1.3%-19.7%
May 2026NT$96 million+73.8%+48.8%
Apr 2026NT$64.5 million+12.8%-32.1%
Mar 2026NT$95.1 million+40.5%+74.0%
Feb 2026NT$54.6 million-26.6%-26.8%
Jan 2026NT$74.6 million+39.1%+0.3%
Dec 2025NT$74.4 million-7.3%-26.4%
Nov 2025NT$101 million+17.9%+67.2%
Oct 2025NT$60.4 million-2.4%-25.4%
Sep 2025NT$81 million-0.9%+21.6%
Aug 2025NT$66.6 million+6.9%-1.5%
Jul 2025NT$67.6 million+2.2%-13.5%
Jun 2025NT$78.1 million+27.4%+41.4%
May 2025NT$55.2 million-31.2%-3.4%
Apr 2025NT$57.2 million-13.4%-15.5%
Mar 2025NT$67.7 million-4.2%-9.1%
Feb 2025NT$74.4 million+35.6%+38.7%
Jan 2025NT$53.6 million-43.1%-33.1%
Dec 2024NT$80.2 million+17.0%-6.5%
Nov 2024NT$85.7 million-20.6%+38.5%
Oct 2024NT$61.9 million-11.7%-24.2%

Jan–Oct 2026 cumulative: NT$704.1 million (+6.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Bioptik Technology vs PEC / Bioptik Technology vs Lotus Pharm / Bioptik Technology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16